Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 28 results.
User Information
Export Records
  1. 1.   Acute-phase innate immune responses in SIVmac239-infected Mamu-B*08+ Indian rhesus macaques may contribute to the establishment of elite control
  2. Rosen, Brandon C; Sawatzki, Kaitlin; Ricciardi, Michael J; Smith, Elise; Golez, Inah; Mauter, Jack T; Pedreño-López, Núria; Yrizarry-Medina, Aaron; Weisgrau, Kim L; Vosler, Logan J; Voigt, Thomas B; Louw, Johan J; Tisoncik-Go, Jennifer; Whitmore, Leanne S; Panayiotou, Christakis; Ghosh, Noor; Furlott, Jessica R; Parks, Christopher L; Desrosiers, Ronald C; Lifson,Jeffrey; Rakasz, Eva G; Watkins, David I; Gale, Michael
  3. Frontiers in Immunology. 2024 15: 1478063.
  1. 2.   TIGIT expression on CD8+ T cells correlates with higher cytotoxic capacity
  2. Blazkova, Jana; Huiting, Erin D; Boddapati, Arun Kumar; Shi, Victoria; Whitehead, Emily J; Justement, Jesse S; Nordstrom, Jeffrey; Moir, Susan; Lack, Justin; Chun, Tae-Wook
  3. The Journal of Infectious Diseases. 2021, Nov 16; 224(9): 1599-1604.
  1. 3.   IL-15:IL-15 receptor alpha superagonist complex: High-level co-expression in recombinant mammalian cells, purification and characterization
  2. Han, K. P.; Zhu, X. Y.; Liu, B.; Jeng, E.; Kong, L.; Yovandich, J. L.; Vyas, V. V.; Marcus, W. D.; Chavaillaz, P. A.; Romero, C. A.; Rhode, P. R.; Wong, H. C.
  3. Cytokine. 2011, Dec; 56(3): 804-810.
  1. 4.   Application of a Flow Cytometric Cytotoxicity Assay for Monitoring Cancer Vaccine Trials
  2. Zaritskaya, L.; Shafer-Weaver, K. A.; Gregory, M. K.; Strobl, S. L.; Baseler, M.; Malyguine, A.
  3. Journal of Immunotherapy. 2009 32(2): 186-194.
  1. 5.   An IFNG SNP with an estrogen-like response element selectively enhances promoter expression in peripheral but not lamina propria T cells
  2. Gonsky, R.; Deem, R. L.; Bream, J. H.; Young, H. A.; Targan, S. R.
  3. Genes and Immunity. 2006, Jul; 7(5): 342-351.
  1. 6.   Conditional up-regulation of IL-2 production by p38 MAPK inactivation is mediated by increased Erk1/2 activity
  2. Kogkopoulou, O.; Tzakos, E.; Mavrothalassitis, G.; Baldari, C. T.; Paliogianni, F.; Young, H. A.; Thyphronitis, G.
  3. Journal of Leukocyte Biology. 2006, May; 79(5): 1052-1060.
  1. 7.   Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes
  2. Frahm, N.; Kiepiela, P.; Adams, S.; Linde, C. H.; Hewitt, H. S.; Sango, K.; Feeney, M. E.; Addo, M. M.; Lichterfeld, M.; Lahaie, M. P.; Pae, E.; Wurcel, A. G.; Roach, T.; St John, M. A.; Altfeld, M.; Marincola, F. M.; Moore, C.; Mallal, S.; Carrington, M.; Heckerman, D.; Allen, T. M.; Mullins, J. I.; Korber, B. T.; Goulder, P. J. R.; Walker, B. D.; Br, er
  3. Nature Immunology. 2006, FEB; 7(2): 173-178.
  1. 8.   The adaptive immune response in neonatal cerebral white matter damage
  2. Leviton, A.; Dammann, O.; Durum, S. K.
  3. Annals of Neurology. 2005, DEC; 58(6): 821-828.
  1. 9.   Evidence for the involvement of tyrosine kinase ZAP 70 in nuclear retinoid receptor-dependent transactivation in T lymphocytes
  2. Ishaq, M.; DeGray, G.; Natarajan, V.
  3. Journal of Biological Chemistry. 2005, OCT 7; 280(40): 34152-34158.
  1. 10.   Calcium-dependent activation of interleukin-21 gene expression in T cells
  2. Kim, H. P.; Korn, L. L.; Gamero, A. M.; Leonard, W. J.
  3. Journal of Biological Chemistry. 2005, JUL 1; 280(26): 25291-25297.
  1. 11.   Transduction of the gene coding for a human G-protein coupled receptor FPRL1 in mouse tumor cells increases host anti-tumor immunity
  2. Hu, J. Y.; Li, G. C.; Tong, Y. Q.; Li, Y. H.; Zhou, G. H.; He, X. J.; Xie, P. L.; Wang, J. M.; Sun, Q. B.
  3. International Immunopharmacology. 2005, JUN; 5(6): 971-980.
  1. 12.   A novel flow cytometric assay for evaluating cell-mediated cytotoxicity
  2. Burkett, M. W.; Weaver, K. A. S.; Strobl, S.; Baseler, M.; Malyguine, A.
  3. Journal of Immunotherapy. 2005, JUL-AUG; 28(4): 396-402.
  1. 13.   Induction of human T cell leukemia virus type I receptors on quiescent naive T lymphocytes by TGF-beta(1,2)
  2. Jones, K. S.; Akel, S.; Petrow-Sadowski, C.; Huang, Y.; Bertolette, D. C.; Ruscetti, F. W.
  3. Journal of Immunology. 2005 174(7): 4262-4270.
  1. 14.   Insufficient production and tissue delivery of CD4(+) memory T cells in rapidly progressive simian immunodeficiency virus infection
  2. Picker, L. J.; Hagen, S. I.; Lum, R.; Reed-Inderbitzin, E. F.; Daly, L. M.; Sylwester, A. W.; Walker, J. M.; Siess, D. C.; Piatak, M.; Wang, C. X.; Allison, D. B.; Maino, V. C.; Lifson, J. D.; Kodama, T.; Axthelm, M. K.
  3. Journal of Experimental Medicine. 2004, NOV 15; 200(10): 1299-1314.
  1. 15.   Rac1 mediates collapse of microvilli on chemokine-activated T lymphocytes
  2. Nijhara, R.; van Hennik, P. B.; Gignac, M. L.; Kruhlak, M. J.; Hordijk, P. L.; Delon, J.; Shaw, S.
  3. Journal of Immunology. 2004, OCT 15; 173(8): 4985-4993.
  1. 16.   Comparison of benchtop microplate beta counters with the traditional gamma counting method for measurement of chromium-51 release in cytotoxic assays
  2. Wallace, D.; Hildesheim, A.; Pinto, L. A.
  3. Clinical and Diagnostic Laboratory Immunology. 2004 11(2): 255-260.
  1. 17.   Effects of IL-7 and dexamethasone: Induction of CD25, the high affinity IL-2 receptor, on human CD4(+) cells
  2. Chung, I. Y.; Dong, H. F.; Zhang, X.; Hassanein, N. M. A.; Howard, O. M. Z.; Oppenheim, J. J.; Chen, X.
  3. Cellular Immunology. 2004, NOV-DEC; 232(1-2): 57-63.
  1. 18.   Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover
  2. Anthony, K. B.; Yoder, C.; Metcalf, J. A.; DerSimonian, R.; Orenstein, J. M.; Stevens, R. A.; Falloon, J.; Polis, M. A.; Lane, H. C.; Sereti, I.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2003 33(2): 125-133.
  1. 19.   Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways
  2. Nagy, Z. S.; Wang, Y. L.; Erwin-Cohen, R. A.; Aradi, J.; Monia, B.; Wang, L. H.; Stepkowski, S. M.; Rui, H.; Kirken, R. A.
  3. Journal of Leukocyte Biology. 2002 72(4): 819-828.
  1. 20.   Efficiency of interphase fluorescence in situ hybridization for BCR/ABL on peripheral blood smears for monitoring of CML patients: a comparison with bone marrow findings
  2. Akel, S.; Kolialexi, A.; Mavrou, A.; Metaxotou, C.; Loukopoulos, D.; Yataganas, X.
  3. Clinical and Laboratory Haematology. 2002 24(6): 361-367.
  1. 21.   Analysis of the costimulatory requirements for generating human virus-specific in vitro T helper and effector responses
  2. Blazevic, V.; Mac Trubey, C.; Shearer, G. M.
  3. Journal of Clinical Immunology. 2001 21(4): 293-302.
  1. 22.   A molecular analysis of NKT cells: identification of a class-I restricted T cell-associated molecule (CRTAM)
  2. Kennedy, J.; Vicari, A. P.; Saylor, V.; Zurawski, S. M.; Copeland, N. G.; Gilbert, D. J.; Jenkins, N. A.; Zlotnik, A.
  3. Journal of Leukocyte Biology. 2000 67(5): 725-734.
  1. 23.   The interleukin 7 receptor is required for T cell receptor gamma locus accessibility to the V(D)J recombinase
  2. Schlissel, M. S.; Durum, S. D.; Muegge, K.
  3. Journal of Experimental Medicine. 2000 191(6): 1045-1050.
  1. 24.   Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells
  2. Yang, D.; Chen, Q.; Chertov, O.; Oppenheim, J. J.
  3. Journal of Leukocyte Biology. 2000 68(1): 9-14.
  1. 25.   Expression of IL-17 in human memory CD45RO(+) T lymphocytes and its regulation by protein kinase A pathway
  2. Shin, H. C. K.; Benbernou, N.; Esnault, S.; Guenounou, M.
  3. Cytokine. 1999 11(4): 257-266.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel